FMR LLC - THERAVANCE INC ownership

THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 29 filers reported holding THERAVANCE INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2022$79,904
+1.1%
80,0000.0%0.00%
Q3 2022$79,0000.0%80,0000.0%0.00%
Q2 2022$79,000
-10.2%
80,0000.0%0.00%
Q1 2022$88,000
+1.1%
80,0000.0%0.00%
Q4 2021$87,000
+1.2%
80,0000.0%0.00%
Q3 2021$86,000
+6.2%
80,0000.0%0.00%
Q2 2021$81,000
+1.2%
80,0000.0%0.00%
Q1 2021$80,000
-91.4%
80,000
-91.4%
0.00%
Q4 2020$930,000
-58.4%
935,000
-60.0%
0.00%
Q3 2020$2,235,000
-3.0%
2,335,0000.0%0.00%
Q2 2020$2,304,000
+6.1%
2,335,0000.0%0.00%
Q1 2020$2,171,000
-7.2%
2,335,0000.0%0.00%
Q4 2019$2,340,000
+6.8%
2,335,0000.0%0.00%
Q3 2019$2,192,000
-45.5%
2,335,000
-39.1%
0.00%
Q2 2019$4,022,000
+3.4%
3,835,0000.0%0.00%
Q1 2019$3,890,000
+17.8%
3,835,000
+25.5%
0.00%
Q4 2018$3,301,000
+11.6%
3,055,000
+4.6%
0.00%
Q3 2018$2,958,000
+3692.3%
2,920,000
+3550.0%
0.00%
Q2 2018$78,000
-9.3%
80,0000.0%0.00%
Q1 2018$86,000
+75.5%
80,000
+60.0%
0.00%
Q4 2017$49,000
-99.9%
50,000
-99.9%
0.00%
-100.0%
Q3 2014$54,291,000
-34.0%
56,850,000
-0.3%
0.01%
-36.4%
Q2 2014$82,280,000
+51.8%
57,040,000
+35.8%
0.01%
+37.5%
Q1 2014$54,207,000
+8.5%
42,000,000
+21.4%
0.01%
+14.3%
Q4 2013$49,983,000
-25.0%
34,590,000
-15.0%
0.01%
-30.0%
Q3 2013$66,672,000
+54.3%
40,700,000
+45.1%
0.01%
+42.9%
Q2 2013$43,215,00028,050,0000.01%
Other shareholders
THERAVANCE INC shareholders Q1 2021
NameSharesValueWeighting ↓
LINDEN ADVISORS LP 78,022,000$72,798,0001.29%
Opti Capital Management, LP 5,200$4,850,0000.99%
Shaolin Capital Management LLC 7,500,000$6,983,0000.97%
ADVENT CAPITAL MANAGEMENT /DE/ 36,159,000$33,613,0000.73%
Castle Creek Arbitrage, LLC 3,583,000$3,338,0000.54%
AQR Arbitrage LLC 16,543,000$15,441,0000.52%
DeepCurrents Investment Group LLC 7,500,000$6,997,0000.34%
CSS LLC/IL 3,484,000$3,257,0000.26%
SSI INVESTMENT MANAGEMENT LLC 2,800,000$2,604,0000.23%
Polar Asset Management Partners Inc. 7,000,000$6,521,0000.13%
View complete list of THERAVANCE INC shareholders